Abionic SA
PrivateLast Round
Series C
Mar 28, 2018
Total Funding Raised
$28.97M
Company Overview
Abionic SA operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Series C round in March 2018.
Abionic SA is a medical technology company that develops and manufactures ultra-rapid in vitro diagnostic solutions using proprietary nanofluidic technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abionic SA Comparables
Compare Abionic SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoDx | 84% | |
| Novus Diagnostics | 84% | |
| SphingoTec | 82% |
For institutional investors. Book with your work email.
Abionic SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 28, 2018 | ||||
| Series B | Oct 14, 2014 | ||||
| Series A | Apr 26, 2012 | ||||
| Accelerator | Oct 1, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abionic SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Series C |
| Business Angels Switzerland | Series A |
| Immo Dumas | Series C |
| Venture Kick | Accelerator |
| PolyTech Ventures | Series A |
| Zurcher Kantonalbank | Series C |
| Drexel Morgan & Co. | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 214% MoM, reaching 2.1K.
- Mar 28, 2018
$21M round led by Pierangelo Bottinelli.
For institutional investors. Book with your work email.
Abionic SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abionic SA's valuation, stock price, and market status.
Is Abionic SA a public or private company?
Abionic SA is a private company.
What is the current stock price of Abionic SA?
Abionic SA is a private company, so its shares have no public market price. Caplight tracks Abionic SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abionic SA worth (valuation)?
Valuation information for Abionic SA is not publicly available.
Can I buy Abionic SA stock?
Abionic SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abionic SA's last funding round?
Abionic SA's most recent funding round was Series C on March 28, 2018.
Who are the main investors in Abionic SA?
Key investors in Abionic SA include Verve Ventures, Business Angels Switzerland, Immo Dumas, Venture Kick, PolyTech Ventures.
Will Abionic SA IPO soon?
No public IPO plans have been announced for Abionic SA.
How can I track Abionic SA secondary market activity?
Caplight tracks bids, offers, and trades in Abionic SA's shares on secondary markets.